Visceral leishmaniasis: Novartis and DNDi to jointly develop a new oral drug - Outbreak News Today

Visceral leishmaniasis: Novartis and DNDi to jointly develop a new oral drug  Outbreak News Today

Comments

Popular posts from this blog

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows - News-Medical.Net

This Nurse Built a Clinic in the Sierra Leone Village Where She Grew Up. That’s Just the Beginning. - Direct Relief